{"id":"W2770192733","doi":"10.1016/j.atherosclerosis.2017.11.014","title":"Reply to: “PCSK9 antagonists and inflammation”","year":2017,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"PCSK9; Inflammation; Alirocumab; Medicine; Canakinumab; Internal medicine; Cholesterol; Endocrinology; LDL receptor; Apolipoprotein B; Lipoprotein; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004827346,0.001414588,0.002621056,0.001020271,0.006344294,0.006756695,0.002227553,0.09704531,0.009960921],"category_scores_gemma":[0.04111471,0.001376327,0.001923688,0.0008872185,0.004655978,0.004976817,0.004446372,0.07270432,0.01084626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004977827,"about_ca_system_score_gemma":0.007100203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004551778,"about_ca_topic_score_gemma":0.006289744,"domain_scores_codex":[0.9952002,0.001317599,0.0006969539,0.000597877,0.001287231,0.0009001311],"domain_scores_gemma":[0.9881108,0.006621889,0.001198334,0.0003143715,0.002091761,0.001662876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004734555,0.00001322198,0.0002780546,0.00004032287,0.00001619443,0.0005987033,0.00008611298,0.00002832116,0.00005279451,0.0009669514,0.9949162,0.002955824],"study_design_scores_gemma":[0.000298942,0.00009198325,0.001084961,0.0006852889,0.00009342563,0.001349073,0.0006063387,0.0003689988,0.0002373371,0.008682983,0.9863839,0.0001167624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001157237,0.001345933,0.00003856173,0.969577,0.02804049,0.000008083008,0.0000425799,0.00001391277,0.0008177844],"genre_scores_gemma":[0.0008980427,0.0007146505,0.00004821644,0.9499857,0.04589746,0.00002395025,0.00002469626,0.00001187435,0.002395466],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.09704531,"threshold_uncertainty_score":0.03611678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02662811122925662,"score_gpt":0.2715917686241107,"score_spread":0.244963657394854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}